This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert E. Brummett, PhD; Richard T. Brown

Arch Otolaryngol. 1975;101(9):540-543.

Abstract
• Tobramycin was administered intravenously to guinea pigs and was shown to produce an impairment of the alternating current cochlear potential. This effect is temporary and occurs only when the blood pressure has been severely lowered. We conclude that these data do not represent the onset of ototoxicity of tobramycin as reported by others, but only represents the cochlear effect of the pronounced fall in blood pressure that is produced by the tobramycin.

(Arch Otolaryngol 101:540-543, 1975)

Author Affiliations
From the Kresge Hearing Research Laboratory, University of Oregon Health Sciences Center, Portland.

Footnotes
Accepted for publication May 16, 1975.

Reprint requests to the Kresge Hearing Research Laboratory, 3515 SW Veterans Rd, Portland, OR 97201 (Dr. Brummett).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?